Community Based Health Education for Prevention of Pelvic Floor Dysfunction in Fertile Women in Rural China

Sponsor
Peking University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05595967
Collaborator
(none)
1,139
1
2
11.6
98.5

Study Details

Study Description

Brief Summary

According to the experts in charge of the healthcare department in the Liangshan area, Liangshan is one of the largest Yi inhabited areas in China. Influenced by local culture and production history, most women there are multiparas, with more than one child, and their awareness of postpartum recovery is relatively weak. Therefore, the prevalence and incidence rate of pelvic floor dysfunction diseases is high in the Liangshan area.

In addition, women in the Liangshan area shoulder the responsibility of taking care of family members, farmland, and livestock. They play an important role in family production, which guarantees the opportunity for other family members to go out to work. However, pelvic floor dysfunction can be manifested by persistent pelvic distension, frequent urination, the urgency of urination, difficulty in urination or defecation, and pain or difficulty in sexual intercourse, which decreases the quality of normal life, and the efficiency of production, posing many psychological problems and family contradictions.

There is no research to prove the exact intervention measures that can effectively improve the pelvic floor function of women in Liangshan ethnic minority areas. This study aims to promote the formation of women's healthy living habits and behaviors, improve women's pelvic floor function, and then develop the quality of life and labor output of local women through intervention including health knowledge education and pelvic floor muscle exercise.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health education intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1139 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Prevention
Official Title:
Community Based Health Education for Prevention of Pelvic Floor Dysfunction in Fertile Women in Rural China: Study Protocol for a Non-randomised Cluster Controlled Trial
Actual Study Start Date :
Aug 18, 2022
Anticipated Primary Completion Date :
Jul 30, 2023
Anticipated Study Completion Date :
Aug 5, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Health education intervention

According the data collected in baseline survey, all participants will be divided into two groups: asymptomatic or mildly symptomatic and severe according the risk level of pelvic floor dysfunction. Intervention for high risk of pelvic floor women focus on emphasizing the need for medical care and access to medical resourced. The first intervention will be performed immediately after baseline survey. The second intervention will be repeated with the first one and performed three months after the first intervention. Both the two session contains modules focusing on heath related knowledge and pelvic floor muscle exercise.

Behavioral: Health education intervention
Both the two session contains modules focusing on heath related knowledge and pelvic floor muscle exercise. Both two session will be delivered by primary healthcare women workers in small groups (about 20 women per group). The local healthcare workers are responsible for making appointment with each participant through group activities. Each participant will receive a healthy calendar practice to record the number of exercises per day which will be supervised by primary healthcare workers. All healthcare workers are required to attend a full-day workshop organized base on the scheme and teaching materials developed by our research team. The contents of the workshop include: (1) introduction of pelvic floor dysfunction; (2) risk factors and prevention of pelvic floor dysfunction; (3) kegel movement; (4) methods of dealing with severe illness; (5) a standard procedure of group activities or one-on-one activities; (6) skills needed for the delivery of health education intervention.

No Intervention: Control without intervention

No health education is provided to the participants in the control group so as to investigate the effects of health education. However, materials provided to interventional group will also be sent to the control group after the completion of the study.

Outcome Measures

Primary Outcome Measures

  1. The score of Pelvic Floor Distress Inventory-short form 20 (PFDI-20) [12 weeks after the start of intervention]

    This participant completed questionnaire comprises three subscales with scores ranging from 0 to 100: the Pelvic Organ Prolapse Distress Inventory-6 assessing prolapse symptoms, the ColoRectal-Anal Distress Inventory-8 assessing colorectal/anal symptoms, and the Urinary Distress Inventory-6 assessing urinary symptoms. A higher PFDI-20 score (sum of three subscale scores, range 0-300) indicates a higher symptom burden.

  2. The change in the incidence of pelvic floor dysfunction symptoms [12 weeks after the start of intervention]

    It is defined by the proportion of people who get a PFDI-20 score not equal to 0.

Secondary Outcome Measures

  1. The score of Pelvic Floor Impact Questionnaire-7 (PFIQ-7) [12 weeks after the intervention]

    The Pelvic Floor Impact Questionnaire-7 (PFIQ-7) measuring the changes in condition specific quality of life, which ranges 0-300, with higher scores indicating greater effect.

  2. The score of Prolapse and Incontinence Knowledge Quiz (PIKQ) [12 weeks after the intervention]

    The PIKQ consists of 24 accurate and inaccurate statements related to the epidemiology, pathogenesis, diagnosis and treatment options for urinary incontinence and POP, with which participants were asked if they agreed or disagreed. Each correct response received a score of one, whereas incorrect and "don't know" responses were scored zero. The PIKQ scores (ranging from 0 to 24) were summed and converted to percentages, with higher totals indicating greater pelvic floor knowledge).

  3. Self-reported monthly working days by questionnaire (day) [12 weeks after the intervention]

    This outcome measures the working days of the participants by questionnaire, which indicates whether they are qualified for work.

  4. Self-reported monthly personal income by questionnaire (Yuan) [12 weeks after the intervention]

    This outcome measures the monthly income of the participants by questionnaire, which demonstrates the economic return of their work.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Married women who are 18-65 years old
Exclusion Criteria:
  • Women who are unable to attend the person-to-person health education classes at the first and forth month of the intervention;

  • Women who have received pelvic floor muscle training, pelvic floor muscle health education, pelvic floor muscle surgery within one year of the baseline survey;

  • Women who are planning pregnancy, pregnant, or have delivered a baby in the past 6 months since the baseline survey;

  • Women who are unable to understand the instructions or questions from others.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University China Center for Health Economic Research Beijing Beijing China 100871

Sponsors and Collaborators

  • Peking University

Investigators

  • Principal Investigator: Guoen Liu, PhD, Peking University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yu Sun, Ph.D., Assistant Director, PKU China Center for Health Economic Research (CCHER), Peking University
ClinicalTrials.gov Identifier:
NCT05595967
Other Study ID Numbers:
  • PekingUni_Liangshan
First Posted:
Oct 27, 2022
Last Update Posted:
Nov 1, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 1, 2022